Navigation Links
GHX Achieves SAS 70 Compliance

Company receives unqualified opinion in Type II examination by independent


LOUISVILLE, Colo., April 10 /PRNewswire/ -- GHX has received an unqualified opinion from independent auditors as a result of its first Type II SAS 70 compliance audit. The SAS audit was conducted at GHX's world headquarters in Louisville, Colo. by a major U.S. accounting firm over a period of five months. The audit covered GHX's exchange services, which enable more than 6000 hospitals and other healthcare providers to conduct supply chain transactions with approximately 600 suppliers. An auditor's unqualified or "clean" opinion indicates that there were no exceptions noted during the audit and that the organization has established effectively designated control objectives and activities.

The Statement on Auditing Standards (SAS) No. 70, Service Organizations, developed by the American Institute of Certified Public Accountants (AICPA), is an in-depth audit of a service organization's control objectives and activities, including controls over information technology and related processes. Application services providers (ASPs), such as GHX, must demonstrate that they have adequate controls and safeguards in place when hosting or processing customer data.

GHX underwent a Type II SAS audit, which includes detailed testing of controls over the extended audit period. A Type II audit is more comprehensive than a Type I SAS report, which describes an organization's description of controls at a specific point in time.

According to Charles Denyer, DuPont & Morgan, LLP, "SAS audits are widely becoming known as the 'de facto due diligence document' throughout the country and the world regarding the reporting on an organization's internal controls that have the ability to impact financial reporting."(1)

"GHX takes its responsibility to the organizations we serve very seriously," says Leigh Anderson, GHX Chief Technology Officer and Group Business Leader for GHX Exchange Services. "We are proud of the work we have done to achieve this unqualified opinion and are committed to maintaining the highest standards for the benefit of our growing customer base in the US, Canada, and Europe."

About GHX

GHX enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making. Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B Braun Medical Inc.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Fisher Scientific International, Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc. For more information, visit

(1) Denyer, Charles (2007). An Introduction to SAS 70 Audits for I.T.

Professionals. Techlinks, June 14, 2007.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. Kaiser Permanente Achieves Climate Action Leader Status
3. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
4. LMS integrated obstetrics solution achieves general availability
5. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
6. Pharsight Achieves $7.3 Million in Quarterly Revenue
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
9. Joint Commission International Achieves Accreditation from ISQua
10. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
11. inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... A record ... annual Regional Biotech Conference, organized by the Baruch S. Blumberg Institute. , The institute, ... of the area’s life science and biotechnology leaders for the conference, which focused on ...
(Date:11/30/2015)... ... 30, 2015 , ... A novel class of antimicrobials that ... in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial pathogens, ... molecule analogs that target the functions of SecA, a central part of the ...
(Date:11/30/2015)... Scotch Plains, NJ (PRWEB) , ... November 30, ... ... is their top choice for innovative, patient centered orthopedic care. Led by ... Regardless of your injury or chronic condition, the team at Advocare Orthopedic & ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... November 30, 2015 North America ... expected to grow at a CAGR of 7.6% from 2015 to ... at USD 135.6 million in 2014, and is expected to grow ... According to the new Market Research Report "North America Cardiac ... End User (Hospitals, ambulatory care, others) - Analysis And Forecast To ...
(Date:11/30/2015)...  Kevin Smith has been appointed Chief Commercial ... in wireless monitoring of vital signs.  As CCO ... Mr. Smith will be responsible for the development ... will also directly oversee partnering with US hospitals ... SensiumVitals, the first early warning detection device to ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... ) today announced that the U.S. Food and Drug ... Application (NDA) for an extended release formulation of lorcaserin. ... a chronic weight management treatment in a once-daily dosing ... as an adjunct to a reduced-calorie diet and increased ...
Breaking Medicine Technology: